Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Shiwali Goyal
    Junior Member
    • Aug 2015
    • 9

    #1

    Concentration of lambda dna

    when i checked the qubit concentration of lambda dna (250microgram/microliter), the following readings occurs
    in 1:100 dilution the readings are 0.246ng/µl, 0.236ng/µl, 0.244ng/µl
    in 1:50 dilution the readings are 0.376ng/µl, 0.358ng/µl, 0.360ng/µl
    Since in 1:50 dilution the readings should come almost double of 1:100
    is there any fault in lambda dna as it is expired but its 1:100 concentration is perfect or any fault in qubit.
    thanks in advance
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    250 ug/ul seems very high. 100x dilution of such stock should be 2.5 ug/ul and 50x dilution 5 ug/ul not the figures you have got. If you are using the same stock at the same time for both dilutions then concentration of 50x dilution should be twice as 100x dilution regardless of DNA quality. There could be some issues with pipette or pipetting.

    Comment

    • Shiwali Goyal
      Junior Member
      • Aug 2015
      • 9

      #3
      Thank u so much

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        Today, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 05:39 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 09:56 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 09-29-2026, 09:51 AM
      0 responses
      77 views
      0 reactions
      Last Post SEQadmin2  
      Working...